Bristol-Myers Squibb
BMY
BMY
1,591 hedge funds and large institutions have $64B invested in Bristol-Myers Squibb in 2017 Q2 according to their latest regulatory filings, with 105 funds opening new positions, 573 increasing their positions, 658 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,591
Holders Change
-2
Holders Change %
-0.13%
% of All Funds
39.73%
Holding in Top 10
44
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-2.22%
% of All Funds
1.1%
New
105
Increased
573
Reduced
658
Closed
87
Calls
$1.81B
Puts
$1.51B
Net Calls
+$301M
Net Calls Change
-$57.4M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$562M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$366M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$350M |
| 4 |
Morgan Stanley
New York
|
-$287M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$134M |
